Skip to Main Content

3 ways Biden's COVID-19 approach could impact medtech

While former Vice President Joe Biden and the team he builds won't take office for another two months, the campaign’s plans for COVID-19healthcare and other policy areas offer clues to how changing tides in Washington may impact the medtech industry.

In approaching the top task at hand — getting the pandemic under control — the Democrat's plan includes proposals with implications for the industry, from how diagnostic testing is covered to access to telemedicine services.

In some ways, the act of swapping out administrations, regardless of who's in power, means device makers can anticipate shifts at key government agencies like the FDA.

Read on for the full article from Medtech Dive.